WHAT COVID-19 TAUGHT US

Pandemics like the Bubonic plague and the Spanish Flu were followed by sweeping social, economic and cultural transformations. They also galvanised great improvements in medical science and public policy. Today, the world confronts and battles another pandemic caused by the novel coronavirus and again this period could be marked by great change and reforms. Therefore, this year-ender edition, which also marks Express Pharma’s 26th Anniversary, presents some insights and learnings which will be crucial for India Pharma Inc to survive and thrive in the post-pandemic world.

- 

The pandemic gave the pharma industry an opportunity to reassess its role

SUDARSHAN JAIN, SECRETARY GENERAL, INDIAN PHARMACEUTICALALLIANCE (IPA)

COVID-19 pandemic is one of the greatest humanitarian challenges. We are learning about the virus and the virus is spreading at an unprecedented rate.

While the pandemic posed several new challenges, it also gave the pharma industry an opportunity to reassess its role and emerge as a reliable supplier of high-quality, affordable medicines. This has been a period of significant learning for the Indian industry on all fronts.

Collaboration is the key

The industry worked relentlessly to provide an uninterrupted supply of medicines in India and across the world. The integrated efforts by the industry, Government of India and other stakeholders such as transporters, supply chain partners made it possible for a quick turn-around.

Proactiveness - the need of the hour

The pandemic demanded agility and proactiveness. This began by classifying medicines as essential goods to manufacture and transport including applying for emergency approvals for manufacturing and testing for newer treatments.

Innovation paved the way

The industry responded promptly by evaluating possible utilisation of available drugs (repurpose drugs) and exploring